Dr. Junna is an Assistant Professor of Gastroenterology and Transplant Hepatology at the Cleveland Clinic. Her academic interests include liver transplantation, liver tumors, and DILI including ICI hepatitis and DI-ALH. She is currently the Medical Director of the Liver Tumor Program at the Cleveland Clinic and is passionate about advancing diagnostic and treatment modalities for primary liver cancers and CRLM, including increasing access to liver transplantation.

Adrian Reuben BSc, MBBS, FRCP, FACG, FAASLD, AGAF is an Emeritus Professor of Medicine (January 2015) at the Medical University of South Carolina (MUSC), in Charleston SC, where he created in 1993 and directed for 22 years, the Liver Program. He retired from clinical practice in December 2014. and returned to live permanently in London UK in April 2018.

Dr. Trang VoPham is an Associate Professor of Epidemiology in the Public Health Sciences Division at the Fred Hutchinson Cancer Center and an Affiliate Associate Professor of Epidemiology at the University of Washington. She conducts research on environmental risk factors for cancer using geospatial science. She received a PhD in Epidemiology from the University of Pittsburgh, an MS in Geographic Information Science and Technology from the University of Southern California, and completed a Postdoctoral Fellowship in Cancer Epidemiology at the Harvard T.H.

Longgang Zhao is a postdoctoral researcher at Yale School of Nursing with expertise in nutritional epidemiology and cancer prevention. His research centers on the role of diet, metabolism, and inflammation in the development of liver disease and liver cancer.

Michael (Andrew) Yu is an assistant professor at Emory University where he practices both transplant hepatology and interventional endoscopy. He earned his internal medicine residency and GI/transplant hepatology fellowships at Emory University, followed by advanced endoscopy fellowship at UC Irvine and Hoag. He is interested in the roles of interventional endoscopic ultrasound and bariatric endoscopy in the care of patients with liver disease.

Dr. Nguyen is Professor of Medicine, a Stanford Cancer Institute member and specializes in the treatment and prevention of primary liver cancer such as hepatocellular carcinoma (HCC). <br><br>Dr. Nguyen is also a Professor of Epidemiology and Population Health by courtesy at Stanford. Her clinical and research focus has been liver cancer for the past 20+ years. She is a frequent lecturer for the management and prevention of liver cancer for care providers and researchers at national and international conferences.

Dr. Lee is a transplant hepatologist who treats patients before and after liver transplant. His NIH-funded research program focuses on improving health for patients with alcohol use, metabolic dysfunction, and liver disease, through: 1) early transplant with alcohol; 2) intersection of alcohol and obesity in the liver; 3) public policy and advocacy; 4) novel therapies and translational science. His research has led to lead-author studies in The Lancet, JAMA Internal Medicine, Annals of Internal Medicine, Lancet Public Health, Gastroenterology, Journal of Hepatology, among others.

Dr. Siddiqui is a Professor of Medicine at University of Virginia within the Division of Gastroenterology and Hepatology. He has deep clinical and research interest in MASLD, liver transplantation and interaction between metabolic complications and chronic liver disease.

Kali Zhou, MD MAS is a transplant hepatologist and Assistant Professor in the Division of Gastrointestinal and Liver Diseases, Keck School of Medicine at the University of Southern California. She received her medical degree from Feinberg School of Medicine at Northwestern University, is a Fulbright scholar, and completed a T32 gastroenterology/transplant hepatology fellowship at the University of California, San Francisco, where she also received a Masters in Clinical Research.